Angiotensin I-converting enzyme insertion/deletion polymorphism: potential significance in nephrology

Area of Science:

• Cardiovascular Biology
• Genetics
• Pharmacology

Background:

• The Angiotensin I-converting enzyme (ACE) regulates cardiovascular homeostasis by managing angiotensin II and bradykinin levels.
• ACE gene polymorphisms, particularly the Insertion/Deletion (I/D) variant, are associated with various cardiovascular diseases.
• Understanding the ACE I/D polymorphism's role is crucial for personalized cardiovascular medicine.

Purpose of the Study:

• To review existing literature on the ACE I/D polymorphism and cardiovascular disease.
• To investigate the association between the ACE I/D polymorphism and the antiproteinuric efficacy of ACE inhibitors.
• To explore the genetic basis of cardiovascular disease risk and treatment response.

Main Methods:

• Literature review of prior reports on ACE I/D polymorphism and cardiovascular diseases.
• Analysis of recent study data on the association between ACE I/D polymorphism and antiproteinuric effects of ACE inhibitors.
• Genetic analysis of the ACE gene's insertion/deletion polymorphism in intron 16.

Main Results:

• The ACE gene I/D polymorphism has been identified as a potential genetic marker for cardiovascular diseases.
• Prior reports indicate associations with myocardial infarction, hypertension, cardiomyopathy, and diabetic complications.
• Our recent study specifically examines the link between this polymorphism and the effectiveness of ACE inhibitors in reducing proteinuria.

Conclusions:

• The ACE I/D polymorphism is a significant genetic factor in cardiovascular health and disease.
• Further research is warranted to elucidate the precise mechanisms linking ACE genotype to cardiovascular risk and treatment outcomes.
• The ACE I/D polymorphism may influence therapeutic responses to ACE inhibitors, particularly in managing proteinuria.